NP will continue to raise only what is needed when
Post# of 148169
(Total Views: 771)
Posted On: 06/11/2020 9:43:49 PM
NP will continue to raise only what is needed when it is needed in order to keep dilution to a minimum. After a positive PDUFA decision later this year and/or FDA approval for leronlimab for mild/moderate and/or severe patients, there may be enough free cash flow to not need to raise any money via shares or warrants. The Company has lots of options!
I am curious about the surprise the finance guy had that NP said was coming having to do with the raise of the AS. Anyone have any thoughts?
I am curious about the surprise the finance guy had that NP said was coming having to do with the raise of the AS. Anyone have any thoughts?
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼